Cost-effectiveness of 70-gene MammaPrint Signature in Node-Negative Breast Cancer Cost-effectiveness of 70-gene MammaPrint Signature in Node-Negative Breast Cancer Evidence, Healthcare Economics, MammaPrint, Other Cost-effectiveness of 70-gene MammaPrint Signature in Node-Negative Breast Cancer PUBLICATION: Am J Manag Care. 2010 Dec 1;16(12):e333-42. AUTHORS: Chen Read More kevin2024-03-25T10:57:22-07:00December 21st, 2010|Evidence, Healthcare Economics, MammaPrint, Other| Read More